Who owns SAB BIOTHERAPEUTICS INC?
- Ticker: SABS
- CUSIP Number: 78397t202
Tip: Access positions for across all investors
Analyze quarterly positions in Sab Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Sab Biotherapeutics stock
Who bought or sold SAB BIOTHERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vivo Capital | 11M | $23M | 100% | Sep 2025 |
|
| RA Capital Management | 4.4M | $8.8M | 100% | Sep 2025 |
|
| Commodore Capital | 4.4M | $8.8M | 100% | Sep 2025 |
|
| Woodline Partners | 2.9M | $5.7M | 100% | Sep 2025 |
|
| Sessa Capital IM | 2.2M | $4.4M | 380% | Sep 2025 |
|
| BVF | 933k | $1.9M | 2% | Sep 2025 |
|
| Sphera Funds Management | 566k | $1.1M | 100% | Sep 2025 |
|
| Vanguard Group | 366k | $735k | 30% | Sep 2025 |
|
| HB Wealth Management | 308k | $618k | 100% | Sep 2025 |
|
| AWM Investment Company | 200k | $402k | 100% | Sep 2025 |
|
| Geode Capital Management | 86k | $172k | 1% | Sep 2025 |
|
| Renaissance Technologies | 81k | $163k | 633% | Sep 2025 |
|
| Pathstone Holdings | 51k | $102k | 0% | Sep 2025 |
|
| Virtu Financial | 20k | $40k | 100% | Sep 2025 |
|
| Kovitz Investment Group Partners | 19k | $39k | 0% | Sep 2025 |
|
| First PREMIER Bank | 19k | $38k | 0% | Sep 2025 |
|
| Dimensional Fund Advisors | 16k | $32k | 100% | Sep 2025 |
|
| ADAR1 Capital Management | 15k | $30k | 100% | Sep 2025 |
|
| UBS Group | 13k | $26k | 24% | Sep 2025 |
|
| Kestra Advisory Services | 12k | $24k | 0% | Sep 2025 |
|
| Northern Trust | 11k | $23k | 0% | Sep 2025 |
|
| Goldman Sachs Group | 11k | $23k | 100% | Sep 2025 |
|
| Caxton | 11k | $22k | 100% | Sep 2025 |
|
| BlackRock | 6.3k | $13k | -10% | Sep 2025 |
|
| Advisor Group Holdings | 4.8k | $10k | -2% | Sep 2025 |
|
| Tower Research Capital | 1.6k | $3.1k | 115% | Sep 2025 |
|
| MAI Wealth Advisors | 217.00 | $436.994600 | 0% | Sep 2025 |
|
| Gs Investments | 200.00 | $402.000000 | 0% | Sep 2025 |
|
| Morgan Stanley | 168.00 | $295.008000 | 100% | Jun 2025 |
|
| Jpmorgan Chase & Co | 87.00 | $175.000500 | -16% | Sep 2025 |
|
| SBI Securities | 52.00 | $104.998400 | 4% | Sep 2025 |
|
| Harbour Investments | 50.00 | $101.000000 | 0% | Sep 2025 |
|
Who sold out of Sab Biotherapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Jun 2025 | 17k | $30k |
| Creative Planning | Jun 2025 | 12k | $21k |
| Sachetta | Jun 2025 | 4.1k | $7.2k |